CDC’s “Our Global Voices”: The challenge of global antibiotic policy: Improving access and preventing excess
Ramanan Laxminarayan, director and senior fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP), discusses a recent CDDEP study published in The Lancet, as well as an accompanying commentary, examining access to antibiotics and drug resistance prevention. Laxminarayan writes, “Access to effective antibiotics should be a global priority, and must be balanced with policies that limit the dangerous trends of excess and inappropriate use that have caused the current crisis of resistance” (2/16).